The total return over the past 12 months is +76.42% vs. +16.94% for the S&P 500. So far it's up +43.70% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +76.42% | +19.44% | (34.44%) | N/A | N/A | N/A |
| Total Return CAGR | +76.42% | +19.44% | (34.44%) | N/A | N/A | N/A |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Atea Pharmaceuticals, Inc. (AVIR)
| Year | Start price | End price | AVIR Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $3.57 | $5.13 | +43.70% | +14.51% | +29.19% |
| 2025 | $3.35 | $3.57 | +6.57% | +17.72% | (11.15%) |
| 2024 | $3.05 | $3.35 | +9.84% | +24.89% | (15.05%) |
| 2023 | $4.81 | $3.05 | (36.59%) | +26.19% | (62.78%) |
| 2022 | $8.94 | $4.81 | (46.20%) | (18.17%) | (28.03%) |
| 2021 | $41.78 | $8.94 | (78.60%) | +28.74% | (107.34%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
